Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
YBX1
|
ENSG00000065978.13 | Y-box binding protein 1 |
FOS
|
ENSG00000170345.5 | Fos proto-oncogene, AP-1 transcription factor subunit |
NFYC
|
ENSG00000066136.15 | nuclear transcription factor Y subunit gamma |
NFYA
|
ENSG00000001167.10 | nuclear transcription factor Y subunit alpha |
NFYB
|
ENSG00000120837.3 | nuclear transcription factor Y subunit beta |
CEBPZ
|
ENSG00000115816.9 | CCAAT enhancer binding protein zeta |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
FOS | hg19_v2_chr14_+_75745477_75745680 | 0.64 | 1.5e-04 | Click! |
NFYA | hg19_v2_chr6_+_41040678_41040722 | 0.44 | 1.5e-02 | Click! |
YBX1 | hg19_v2_chr1_+_43148059_43148111 | 0.33 | 7.9e-02 | Click! |
NFYC | hg19_v2_chr1_+_41157671_41157695 | -0.25 | 1.8e-01 | Click! |
NFYB | hg19_v2_chr12_-_104531945_104531996 | 0.17 | 3.8e-01 | Click! |
CEBPZ | hg19_v2_chr2_-_37458749_37458856 | -0.16 | 4.1e-01 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.3 | 22.0 | GO:0031938 | regulation of chromatin silencing at telomere(GO:0031938) |
7.1 | 21.3 | GO:2000775 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) response to DDT(GO:0046680) histone H3-S10 phosphorylation involved in chromosome condensation(GO:2000775) |
5.9 | 17.8 | GO:0007057 | spindle assembly involved in female meiosis I(GO:0007057) |
5.4 | 16.3 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
4.9 | 24.4 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
4.5 | 22.5 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
4.5 | 40.1 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
4.1 | 12.3 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
3.6 | 17.9 | GO:0033490 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
3.1 | 18.7 | GO:0014038 | regulation of Schwann cell differentiation(GO:0014038) |
3.1 | 12.2 | GO:0046125 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
2.9 | 8.7 | GO:0070510 | regulation of histone H4-K20 methylation(GO:0070510) positive regulation of histone H4-K20 methylation(GO:0070512) |
2.9 | 8.7 | GO:1904253 | positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
2.8 | 11.1 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
2.8 | 13.8 | GO:0046504 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
2.7 | 2.7 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
2.5 | 7.6 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
2.5 | 7.4 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
2.5 | 7.4 | GO:0071373 | cellular response to cocaine(GO:0071314) cellular response to luteinizing hormone stimulus(GO:0071373) |
2.4 | 2.4 | GO:0042700 | luteinizing hormone signaling pathway(GO:0042700) |
2.3 | 9.3 | GO:0000915 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
2.3 | 6.8 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
2.2 | 6.7 | GO:0072034 | renal vesicle induction(GO:0072034) |
2.1 | 12.7 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
2.1 | 21.0 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
2.0 | 8.1 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
2.0 | 6.1 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
1.9 | 17.5 | GO:0045338 | farnesyl diphosphate metabolic process(GO:0045338) |
1.9 | 15.5 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
1.9 | 1.9 | GO:1903436 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
1.9 | 7.7 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
1.9 | 11.2 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
1.8 | 5.5 | GO:1903926 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
1.8 | 26.7 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
1.8 | 8.8 | GO:0060744 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
1.8 | 5.3 | GO:1904772 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
1.7 | 8.7 | GO:0019343 | cysteine biosynthetic process via cystathionine(GO:0019343) |
1.6 | 11.4 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
1.5 | 6.2 | GO:0006272 | leading strand elongation(GO:0006272) |
1.5 | 4.6 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
1.5 | 7.6 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
1.4 | 52.0 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
1.4 | 15.9 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
1.4 | 2.8 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
1.4 | 31.5 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
1.3 | 1.3 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
1.3 | 6.5 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
1.3 | 6.3 | GO:0002317 | plasma cell differentiation(GO:0002317) |
1.2 | 6.1 | GO:0019470 | 4-hydroxyproline catabolic process(GO:0019470) |
1.2 | 3.6 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
1.2 | 3.6 | GO:0042663 | regulation of endodermal cell fate specification(GO:0042663) |
1.2 | 4.8 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
1.2 | 3.5 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
1.2 | 11.8 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
1.2 | 4.7 | GO:1904647 | response to rotenone(GO:1904647) |
1.2 | 3.5 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
1.1 | 9.1 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
1.1 | 3.4 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
1.1 | 14.2 | GO:0000733 | DNA strand renaturation(GO:0000733) |
1.0 | 130.5 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
1.0 | 5.0 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.9 | 2.8 | GO:0044209 | AMP salvage(GO:0044209) |
0.9 | 3.7 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.9 | 3.7 | GO:0021592 | fourth ventricle development(GO:0021592) |
0.9 | 21.1 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.9 | 4.5 | GO:1904744 | positive regulation of telomeric DNA binding(GO:1904744) |
0.9 | 21.6 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.9 | 4.5 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.9 | 5.3 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.9 | 11.5 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.9 | 4.4 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.9 | 9.5 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.9 | 18.1 | GO:0043486 | histone exchange(GO:0043486) |
0.8 | 5.9 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
0.8 | 10.1 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) |
0.8 | 17.6 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
0.8 | 2.4 | GO:0000706 | meiotic DNA double-strand break processing(GO:0000706) double-strand break repair involved in meiotic recombination(GO:1990918) |
0.8 | 2.4 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.8 | 31.1 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.8 | 2.3 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
0.7 | 2.2 | GO:0036071 | N-glycan fucosylation(GO:0036071) |
0.7 | 0.7 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.7 | 2.2 | GO:0070638 | nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
0.7 | 7.2 | GO:0030497 | fatty acid elongation(GO:0030497) |
0.7 | 3.6 | GO:2001168 | regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.7 | 4.2 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.7 | 2.1 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.7 | 2.1 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
0.7 | 2.0 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
0.7 | 0.7 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
0.7 | 1.3 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.7 | 35.5 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.6 | 2.6 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.6 | 2.6 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.6 | 3.9 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) determination of liver left/right asymmetry(GO:0071910) |
0.6 | 1.9 | GO:1901860 | positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
0.6 | 1.9 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.6 | 3.8 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.6 | 2.5 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.6 | 0.6 | GO:0019401 | alditol biosynthetic process(GO:0019401) |
0.6 | 3.7 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.6 | 2.4 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.6 | 1.8 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
0.6 | 2.4 | GO:0044805 | late nucleophagy(GO:0044805) |
0.6 | 17.9 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) |
0.6 | 3.6 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.6 | 1.2 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.6 | 16.3 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.6 | 1.7 | GO:0071140 | resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
0.6 | 2.3 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.6 | 1.7 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.6 | 2.3 | GO:0048478 | replication fork protection(GO:0048478) |
0.6 | 1.7 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
0.6 | 6.2 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.6 | 3.9 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.6 | 1.7 | GO:0031247 | actin rod assembly(GO:0031247) |
0.6 | 2.2 | GO:0002545 | chronic inflammatory response to non-antigenic stimulus(GO:0002545) regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002880) |
0.6 | 2.2 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.6 | 1.7 | GO:0042938 | dipeptide transport(GO:0042938) |
0.5 | 3.3 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.5 | 1.6 | GO:0010519 | negative regulation of phospholipase activity(GO:0010519) |
0.5 | 3.2 | GO:0051012 | microtubule sliding(GO:0051012) |
0.5 | 8.9 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.5 | 10.5 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.5 | 19.9 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.5 | 2.6 | GO:0007525 | somatic muscle development(GO:0007525) |
0.5 | 2.1 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.5 | 4.6 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.5 | 2.0 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
0.5 | 2.5 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.5 | 3.0 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.5 | 2.0 | GO:0010481 | ectoderm and mesoderm interaction(GO:0007499) epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) positive regulation of somatic stem cell population maintenance(GO:1904674) |
0.5 | 1.0 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.5 | 1.9 | GO:0006145 | purine nucleobase catabolic process(GO:0006145) xanthine metabolic process(GO:0046110) |
0.5 | 2.8 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.5 | 0.5 | GO:0014870 | response to muscle inactivity(GO:0014870) |
0.5 | 1.4 | GO:0006258 | UDP-glucose catabolic process(GO:0006258) |
0.5 | 1.8 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
0.5 | 5.4 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.4 | 1.3 | GO:0032773 | regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
0.4 | 0.4 | GO:1903921 | protein processing in phagocytic vesicle(GO:1900756) regulation of protein processing in phagocytic vesicle(GO:1903921) positive regulation of protein processing in phagocytic vesicle(GO:1903923) |
0.4 | 1.3 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.4 | 5.3 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.4 | 5.2 | GO:0000022 | mitotic spindle elongation(GO:0000022) |
0.4 | 0.4 | GO:0008204 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
0.4 | 1.7 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.4 | 1.3 | GO:2000412 | activation of MAPK activity involved in innate immune response(GO:0035419) positive regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000309) positive regulation of thymocyte migration(GO:2000412) |
0.4 | 1.3 | GO:1903181 | regulation of dopamine biosynthetic process(GO:1903179) positive regulation of dopamine biosynthetic process(GO:1903181) negative regulation of protein catabolic process in the vacuole(GO:1904351) negative regulation of lysosomal protein catabolic process(GO:1905166) |
0.4 | 23.7 | GO:0007077 | mitotic nuclear envelope disassembly(GO:0007077) |
0.4 | 0.8 | GO:0034599 | cellular response to oxidative stress(GO:0034599) |
0.4 | 3.7 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.4 | 2.0 | GO:0003343 | proepicardium development(GO:0003342) septum transversum development(GO:0003343) |
0.4 | 41.6 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.4 | 2.0 | GO:1904526 | regulation of microtubule binding(GO:1904526) |
0.4 | 3.2 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.4 | 5.1 | GO:0051983 | regulation of chromosome segregation(GO:0051983) |
0.4 | 2.3 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.4 | 23.4 | GO:0035307 | positive regulation of dephosphorylation(GO:0035306) positive regulation of protein dephosphorylation(GO:0035307) |
0.4 | 0.8 | GO:0061043 | regulation of vascular wound healing(GO:0061043) |
0.4 | 2.3 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.4 | 2.3 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.4 | 1.1 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
0.4 | 1.1 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
0.4 | 17.7 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
0.4 | 3.8 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.4 | 5.2 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.4 | 2.6 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
0.4 | 3.0 | GO:0017185 | peptidyl-lysine hydroxylation(GO:0017185) |
0.4 | 6.3 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.4 | 0.4 | GO:0010628 | positive regulation of gene expression(GO:0010628) |
0.4 | 3.7 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.4 | 2.2 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.4 | 12.6 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.4 | 1.4 | GO:0000187 | activation of MAPK activity(GO:0000187) |
0.4 | 1.4 | GO:0010616 | negative regulation of cardiac muscle adaptation(GO:0010616) negative regulation of cardiac muscle hypertrophy in response to stress(GO:1903243) |
0.3 | 1.7 | GO:0030047 | actin modification(GO:0030047) |
0.3 | 1.7 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.3 | 1.0 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.3 | 2.4 | GO:0006868 | glutamine transport(GO:0006868) |
0.3 | 3.4 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.3 | 0.3 | GO:1904867 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.3 | 4.7 | GO:0090178 | regulation of establishment of planar polarity involved in neural tube closure(GO:0090178) planar cell polarity pathway involved in neural tube closure(GO:0090179) |
0.3 | 10.0 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.3 | 0.3 | GO:1904815 | negative regulation of protein localization to chromosome, telomeric region(GO:1904815) |
0.3 | 1.5 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.3 | 0.9 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.3 | 0.9 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.3 | 0.6 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.3 | 5.5 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
0.3 | 1.7 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.3 | 1.7 | GO:0019060 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.3 | 2.6 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.3 | 0.9 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.3 | 0.3 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.3 | 0.8 | GO:0060061 | Spemann organizer formation(GO:0060061) |
0.3 | 0.3 | GO:0071711 | basement membrane organization(GO:0071711) |
0.3 | 1.1 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
0.3 | 0.3 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.3 | 6.7 | GO:0051412 | response to corticosterone(GO:0051412) |
0.3 | 0.8 | GO:0030860 | neuroblast division in subventricular zone(GO:0021849) regulation of polarized epithelial cell differentiation(GO:0030860) |
0.3 | 1.1 | GO:0036510 | trimming of terminal mannose on C branch(GO:0036510) |
0.3 | 2.4 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.3 | 4.3 | GO:0051639 | actin filament network formation(GO:0051639) |
0.3 | 0.5 | GO:0009188 | ADP biosynthetic process(GO:0006172) nucleoside diphosphate biosynthetic process(GO:0009133) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
0.3 | 1.0 | GO:0090399 | replicative senescence(GO:0090399) |
0.3 | 0.8 | GO:0034063 | stress granule assembly(GO:0034063) |
0.3 | 4.8 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
0.3 | 0.3 | GO:1902669 | positive regulation of axon guidance(GO:1902669) |
0.3 | 2.3 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.3 | 10.8 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
0.3 | 1.5 | GO:0061042 | vascular wound healing(GO:0061042) |
0.2 | 1.5 | GO:0061668 | mitochondrial ribosome assembly(GO:0061668) |
0.2 | 1.7 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.2 | 0.7 | GO:0005988 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) |
0.2 | 1.5 | GO:0046985 | negative regulation of megakaryocyte differentiation(GO:0045653) positive regulation of hemoglobin biosynthetic process(GO:0046985) |
0.2 | 1.9 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.2 | 0.7 | GO:0044691 | tooth eruption(GO:0044691) |
0.2 | 1.7 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
0.2 | 1.9 | GO:0006116 | NADH oxidation(GO:0006116) |
0.2 | 1.0 | GO:0072308 | negative regulation by virus of viral protein levels in host cell(GO:0046725) negative regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072308) |
0.2 | 1.4 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
0.2 | 0.2 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.2 | 1.2 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.2 | 14.6 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.2 | 0.7 | GO:2000687 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
0.2 | 0.2 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
0.2 | 3.5 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.2 | 0.7 | GO:0061743 | motor learning(GO:0061743) |
0.2 | 1.6 | GO:0019236 | response to pheromone(GO:0019236) |
0.2 | 1.4 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.2 | 0.5 | GO:0045667 | regulation of osteoblast differentiation(GO:0045667) |
0.2 | 1.2 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.2 | 2.7 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.2 | 0.5 | GO:0010212 | response to ionizing radiation(GO:0010212) |
0.2 | 0.4 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.2 | 0.7 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
0.2 | 2.2 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
0.2 | 2.6 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.2 | 0.6 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
0.2 | 2.8 | GO:0042407 | cristae formation(GO:0042407) |
0.2 | 3.8 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.2 | 0.8 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.2 | 0.6 | GO:0045648 | positive regulation of erythrocyte differentiation(GO:0045648) |
0.2 | 1.0 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.2 | 0.8 | GO:0043046 | DNA methylation involved in gamete generation(GO:0043046) |
0.2 | 1.5 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.2 | 2.5 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
0.2 | 0.8 | GO:1902164 | platelet alpha granule organization(GO:0070889) regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
0.2 | 1.8 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.2 | 0.6 | GO:0072579 | molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
0.2 | 1.0 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.2 | 0.8 | GO:0032690 | negative regulation of interleukin-1 alpha production(GO:0032690) negative regulation of interleukin-1 alpha secretion(GO:0050712) |
0.2 | 0.6 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.2 | 0.2 | GO:1904030 | negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.2 | 1.8 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.2 | 1.6 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.2 | 0.4 | GO:0009149 | pyrimidine nucleoside triphosphate catabolic process(GO:0009149) pyrimidine deoxyribonucleoside triphosphate catabolic process(GO:0009213) |
0.2 | 1.0 | GO:1990834 | response to odorant(GO:1990834) |
0.2 | 1.6 | GO:0002934 | desmosome organization(GO:0002934) |
0.2 | 0.6 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
0.2 | 2.1 | GO:0021830 | interneuron migration from the subpallium to the cortex(GO:0021830) |
0.2 | 0.2 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.2 | 2.4 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.2 | 1.1 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
0.2 | 1.7 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.2 | 0.7 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.2 | 0.6 | GO:0061198 | fungiform papilla formation(GO:0061198) |
0.2 | 3.7 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.2 | 0.5 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.2 | 0.5 | GO:0001928 | regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
0.2 | 1.1 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.2 | 0.7 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.2 | 2.3 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.2 | 1.4 | GO:0045005 | DNA-dependent DNA replication maintenance of fidelity(GO:0045005) |
0.2 | 0.5 | GO:0098905 | regulation of bundle of His cell action potential(GO:0098905) |
0.2 | 0.2 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.2 | 0.7 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) |
0.2 | 0.9 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.2 | 3.1 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
0.2 | 7.0 | GO:0032392 | DNA geometric change(GO:0032392) |
0.2 | 0.7 | GO:0007231 | osmosensory signaling pathway(GO:0007231) |
0.2 | 0.8 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.2 | 3.7 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.2 | 1.0 | GO:0072602 | interleukin-33-mediated signaling pathway(GO:0038172) interleukin-4 secretion(GO:0072602) |
0.2 | 1.3 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
0.2 | 4.5 | GO:0050687 | negative regulation of defense response to virus(GO:0050687) |
0.2 | 0.5 | GO:0060940 | epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
0.2 | 3.6 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.2 | 1.5 | GO:0046618 | drug export(GO:0046618) |
0.2 | 0.5 | GO:0003198 | epithelial to mesenchymal transition involved in endocardial cushion formation(GO:0003198) |
0.2 | 2.1 | GO:0034976 | response to endoplasmic reticulum stress(GO:0034976) |
0.2 | 3.4 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.2 | 0.5 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.2 | 0.9 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
0.2 | 0.2 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.2 | 0.3 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
0.2 | 11.7 | GO:0055092 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.2 | 0.6 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.2 | 4.9 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.2 | 2.1 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.7 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.1 | 1.6 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) |
0.1 | 2.4 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.1 | 0.9 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 2.1 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.1 | 0.6 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.1 | 0.7 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
0.1 | 1.5 | GO:0010165 |